 Connection
Ross Kedl to Protein Binding
This is a "connection" page, showing publications Ross Kedl has written about Protein Binding.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.103 |
|
|
|
-
McWilliams JA, McGurran SM, Dow SW, Slansky JE, Kedl RM. A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model. J Immunol. 2006 Jul 01; 177(1):155-61.
Score: 0.039
-
Yan H, Wang R, Viswanadhapalli S, Cervantes C, He F, Wu S, Khosh A, Luo W, Wang J, Fernandez MJ, Pratap UP, Khan M, Hinton K, Vankamamidi SE, Perez D, Rivera CE, Gupta HB, Zhang F, Ye Z, Chen Y, Li XD, Sareddy GR, Zan H, Li Y, Wang E, Bunnik EM, Zhong G, Hunter CA, Kedl RM, Yin Z, Min B, Ebrahimi D, Zheng S, Curiel TJ, Xiang Y, Vadlamudi RK, Casali P, Xu Z. Ligand-receptor interactions induce and mediate regulatory functions of BATF3+ B cells. Sci Adv. 2025 Oct 10; 11(41):eadx9917.
Score: 0.037
-
Torphy RJ, Sun Y, Lin R, Caffrey-Carr A, Fujiwara Y, Ho F, Miller EN, McCarter MD, Lyons TR, Schulick RD, Kedl RM, Zhu Y. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models. Nat Commun. 2022 01 10; 13(1):97.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|